Read + Share
Amedeo Smart
Independent Medical Education
Camargo JA, Lee MC, Souza MM, Silva LPD, et al. MMP9 Knockout by CRISPR-Cas9 Reduces Bladder Cancer Malignancy But Does Not Synergize With BCG and Anti-PD-L1 in an Orthotopic Mouse Model. IUBMB Life 2026;78:e70130.PMID: 42706676
Email
LinkedIn
Privacy Policy